The Week in Weed: October 25, 2019


Welcome back to The Week in Weed, your Friday appear at what’s taking place in the planet of legalized marijuana.

Hemp was in the news pretty a bit this week.  The 2019 edition of the Hemp and CBD Business Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that quantity could hit $10 billion by 2024.

But there are some hiccups on the way to that massive quantity.  1st, the federal government is seizing hemp imports at the border in spite of legalization.  Revolutionary Nutraceuticals LLC has brought suit in California federal court to cease this practice.

Meanwhile, the FDA and FTC are cracking down on a single company’s healthcare claims.  Rooted Apothecary received this letter from the agencies telling it to cease promoting unapproved solutions with unsubstantiated claims.

And South Dakota nonetheless has complications with hemp.  A Colorado man has been indicted by a grand jury for transporting the item by means of the state to Minnesota.  Granted, it is considerably longer to go by means of Wyoming, Montana and North Dakota to get to Minnesota from Colorado, but it would nonetheless be shorter than serving a 15 year prison sentence.

It wasn’t all about hemp this week.  You will doubtless recall that final week we reported that two of Rudy Giuliani’s associates have been attempting to involve themselves in the Nevada marijuana sector.  Turns out, they have been attempting to get into cannabis in Florida as nicely.

In federal tax news, the U.S. Tax Court ruled this week that the tax code ban on small business deductions by healthcare marijuana corporations is constitutional.  The case is Northern California Tiny Organization Assistants Inc. v. Commissioner of Internal Income, docket quantity 26889-16.

And of course, there’s news from the states.  Let’s get started in the northeast, exactly where the governors of 4 states (New York, New Jersey, Connecticut and Pennsylvania) met to go over coordinating their states’ cannabis policies.  All 4 are supporters of adult-use legalization.  Perhaps Colorado ought to convene anything equivalent to get South Dakota on board with hemp?

Speaking of Connecticut, the state just added numerous circumstances to the list of permissible utilizes of healthcare marijuana.  Tourette syndrome and intractable neuropathic discomfort are now eligible for remedy with healthcare cannabis.

Rhode Island was not at the governors’ meeting, probably since the governor and the legislature are involved in a lawsuit.  The governor says the legislature is attempting to veto executive regulations the legislators say they will get rid of the provision from the law.

The news wasn’t completely from the East Coast.  New Mexico’s legalization job force has released its final report.  It would permit for expungement of low-level marijuana convictions, but would not permit property expanding.

Cannabis study was also a massive subject.  The University of California San Diego has just gotten state approval to study the medicinal worth of marijuana (specifically CBD) as of January 1, 2020.  This will probably please former VA Secretary David Shulkin, who not too long ago named for additional study into healthcare marijuana.  And Senator John Cornyn (R-TX) voiced his assistance for additional study at a Congressional hearing this week.  Which is cold comfort for the Scottsdale Analysis Institute (subscription needed), which saw the D.C. Circuit Court refuse to involve itself in the company’s fight with the DEA more than cannabis study licenses.

Ultimately, what on earth is going on in Oklahoma?  The Common Counsel of the state’s Division of Overall health sent herself threatening messages, purporting to be from cannabis advocates.  What a lengthy, strange trip it has been.

See you subsequent week!


Latest posts